News
RGEN
144.88
+0.44%
0.64
Weekly Report: what happened at RGEN last week (0706-0710)?
Weekly Report · 17h ago
Can Repligen (RGEN) Stay Undervalued On Russell Index Removals And Margin Concerns?
Simply Wall St · 4d ago
Should Repligen's (RGEN) Russell Growth Index Removal Require Action From Current Investors?
Simply Wall St · 5d ago
SpaceX initiated, Cloudflare upgraded: Wall Street’s top analyst calls
TipRanks · 6d ago
Repligen Price Target Announced at $185.00/Share by Benchmark
Dow Jones · 6d ago
Repligen Raised to Buy From Hold by Benchmark
Dow Jones · 6d ago
Benchmark Upgrades Repligen to Buy, Announces $185 Price Target
Benzinga · 6d ago
REPLIGEN CORP <RGEN.O>: BENCHMARK RAISES TO BUY FROM HOLD
Reuters · 6d ago
Repligen upgraded to Buy from Hold at Benchmark
TipRanks · 6d ago
Repligen Price Target Raised to $160.00/Share From $150.00 by Evercore ISI Group
Dow Jones · 07/06 17:06
Repligen Is Maintained at Outperform by Evercore ISI Group
Dow Jones · 07/06 17:06
Evercore ISI Group Maintains Outperform on Repligen, Raises Price Target to $160
Benzinga · 07/06 16:56
Weekly Report: what happened at RGEN last week (0629-0703)?
Weekly Report · 07/06 10:09
Q/C Technologies relocates headquarters to San Francisco, sets up 4,800-square-foot photonics lab
PUBT · 07/02 21:02
William Blair updates conviction list: Oracle in, Meta out and more
Seeking Alpha · 07/01 11:26
Q/C Technologies relocates headquarters to San Francisco from New York City
PUBT · 06/30 13:15
Weekly Report: what happened at RGEN last week (0622-0626)?
Weekly Report · 06/29 10:05
BioLife is said to have drawn takeover interest from Repligen
Seeking Alpha · 06/27 16:20
Repligen (RGEN) Could Be 20% Undervalued After Q1 Guidance Cooled Growth Hopes
Simply Wall St · 06/27 00:21
Biolife attracts takeover interest from Repligen, Bloomberg says
TipRanks · 06/26 22:15
More
Webull provides a variety of real-time RGEN stock news. You can receive the latest news about Repligen through multiple platforms. This information may help you make smarter investment decisions.
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.